NCT05838690 Optimizing Tracheal Intubation Outcomes and Neonatal Safety
| NCT ID | NCT05838690 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Infant |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2023-04-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to assess the impact of a personalized intubation planning tool, the Personalized INtubation Safety (PINS) Bundle on intubation procedural safety and clinical outcomes among patients intubated in the neonatal intensive care unit (NICU) setting.
Eligibility Criteria
Inclusion Criteria: Infants undergoing tracheal intubation in the neonatal intensive care unit (NICU) Exclusion Criteria: Endotracheal tube exchanges, as this represents a distinct procedure.
Contact & Investigator
Elizabeth Foglia, MD
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT05838690 clinical trial?
This trial is open to participants of all sexes, up to 1 Year, studying Infant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05838690 currently recruiting?
Yes, NCT05838690 is actively recruiting participants. Contact the research team at foglia@chop.edu for enrollment information.
Where is the NCT05838690 trial being conducted?
This trial is being conducted at Little Rock, United States, Denver, United States, New Haven, United States, Lebanon, United States and 4 additional locations.
Who is sponsoring the NCT05838690 clinical trial?
NCT05838690 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Elizabeth Foglia, MD at Children's Hospital of Philadelphia. The trial plans to enroll 3,000 participants.